Loading…
Import this data to Google Sheets with:
=jivedata("APTV-WI","financials")Full statements spill as a table. For one cell: =jivedata("APTV-WI","Revenue") or =jivedata("APTV-WI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
APTV-WI • CIK 0001521332
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $20,051,000 | $19,713,000 | $20,398,000 | $16,671,000 |
| Operating Income (Loss) | $1,559,000 | $1,842,000 | $1,184,000 | $891,000 |
| Interest Expense | $285,000 | $337,000 | $361,000 | $361,000 |
| Other Nonoperating Income (Expense) | $9,000 | $-2,000 | $50,000 | $93,000 |
| Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee | — | $605,000 | $46,000 | $3,000 |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $1,337,000 | $2,151,000 | $919,000 | $664,000 |
| Income Tax Expense (Benefit) | $-1,928,000 | $223,000 | $700,000 | $393,000 |
| Income (Loss) from Equity Method Investments | $-299,000 | $-118,000 | $-38,000 | $-51,000 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $2,966,000 | $1,810,000 | $181,000 | $233,000 |
| Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | — | — | $19,000 | $16,000 |
| Net Income (Loss) Attributable to Redeemable Noncontrolling Interest | $0 | $-1,000 | $-3,000 | $-3,000 |
| Net Income (Loss) Attributable to Parent | $2,938,000 | $1,787,000 | $165,000 | $220,000 |
| Preferred Stock Dividends, Income Statement Impact | $29,000 | $0 | $0 | $0 |
| Net Income (Loss) Available to Common Stockholders, Basic | $2,909,000 | $1,787,000 | $165,000 | $165,000 |
| Cost of Goods and Services Sold | $16,612,000 | $16,002,000 | $16,500,000 | $13,245,000 |
| Selling, General and Administrative Expense | $1,436,000 | $1,465,000 | $1,673,000 | $1,543,000 |
| Amortization of Intangible Assets | $233,000 | $211,000 | $208,000 | $208,000 |
| Restructuring Charges | $211,000 | $193,000 | $185,000 | $136,000 |
| Goodwill, Impairment Loss | $0 | $0 | $648,000 | $648,000 |
| Costs and Expenses | $18,492,000 | $17,871,000 | $19,214,000 | $15,780,000 |
| Weighted Average Number of Shares Outstanding, Basic | 276,920,000 | 256,380,000 | 220,000,000 | 207,930,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 282,880,000 | 256,660,000 | 220,750,000 | 208,960,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $1,640,000 | $1,573,000 | $1,851,000 | $761,000 |
| Restricted Cash and Cash Equivalents, Current | — | $1,000 | $3,000 | $4,000 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $3,546,000 | $3,261,000 | $3,477,000 | $2,434,000 |
| Assets | $24,427,000 | $23,458,000 | $23,413,000 | $17,996,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Inventory, Net | $2,365,000 | $2,320,000 | $2,561,000 | $2,038,000 |
| Other Assets, Current | $696,000 | $671,000 | $853,000 | $766,000 |
| Assets, Current | $8,247,000 | $7,826,000 | $8,745,000 | $6,003,000 |
| Property, Plant and Equipment, Net | $3,785,000 | $3,698,000 | $3,774,000 | $2,756,000 |
| Operating Lease, Right-of-Use Asset | $540,000 | $495,000 | $501,000 | $305,000 |
| Equity Method Investments | $1,443,000 | $1,433,000 | $1,431,000 | $1,255,000 |
| Liabilities | $12,583,000 | $14,373,000 | $13,914,000 | $9,243,000 |
| Intangible Assets, Net (Excluding Goodwill) | $2,399,000 | $2,140,000 | $2,004,000 | $1,875,000 |
| Goodwill | $5,151,000 | $5,024,000 | $4,596,000 | $3,937,000 |
| Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests | $99,000 | $92,000 | $102,000 | $0 |
| Other Assets, Noncurrent | $2,862,000 | $2,842,000 | $2,362,000 | $1,865,000 |
| Assets, Noncurrent | $16,180,000 | $15,632,000 | $14,668,000 | $11,993,000 |
| Short-term Debt | $9,000 | $509,000 | $81,000 | $23,000 |
| Accounts Payable, Current | $3,151,000 | $2,870,000 | $3,157,000 | $1,910,000 |
| Accrued Liabilities, Current | $1,648,000 | $1,752,000 | $1,799,000 | $1,042,000 |
| Liabilities, Current | $4,808,000 | $5,131,000 | $5,037,000 | $2,975,000 |
| Long-term Debt, Excluding Current Maturities | $6,204,000 | $7,843,000 | $7,470,000 | $5,331,000 |
| Liability, Defined Benefit Plan, Noncurrent | $417,000 | $374,000 | $430,000 | $212,000 |
| Operating Lease, Liability, Noncurrent | $453,000 | $412,000 | $401,000 | $241,000 |
| Other Liabilities, Noncurrent | $701,000 | $613,000 | $576,000 | $484,000 |
| Liabilities, Noncurrent | $7,775,000 | $9,242,000 | $8,877,000 | $6,268,000 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $3,000 | $2,000 | $2,000 | $2,000 |
| Additional Paid in Capital | $4,028,000 | $2,966,000 | $3,619,000 | $3,613,000 |
| Retained Earnings (Accumulated Deficit) | $8,162,000 | $7,002,000 | $6,227,000 | $5,578,000 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-645,000 | $-1,174,000 | $-641,000 | $-440,000 |
| Stockholders' Equity Attributable to Parent | $11,548,000 | $8,796,000 | $9,207,000 | $8,753,000 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $197,000 | $197,000 | $190,000 | $0 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $11,745,000 | $8,993,000 | $9,397,000 | $8,753,000 |
| Accounts Receivable, Allowance for Credit Loss, Current | $52,000 | $37,000 | $45,000 | $29,000 |
| Preferred Stock, Shares Authorized | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| Common Stock, Shares Authorized | 1,200,000,000 | 1,200,000,000 | 1,200,000,000 | 1,200,000,000 |
| Common Stock, Shares, Issued | 279,033,365 | 235,035,739 | 212,746,899 | 208,365,500 |
| Deferred Tax Assets, Net | $1,957,000 | $1,991,000 | $1,568,000 | $1,568,000 |
| Deferred Tax Liabilities, Net | $222,000 | — | — | $222,000 |
| Derivative Asset, Noncurrent | $23,000 | $1,000 | $34,000 | $8,000 |
| Derivative Liability, Noncurrent | $1,000 | $39,000 | $0 | $1,000 |
| Payments for (Proceeds from) Derivative Instrument, Investing Activities | $-6,000 | $2,000 | $-4,000 | $3,000 |
| Operating Lease, Liability, Current | $121,000 | $124,000 | $142,000 | $89,000 |
| Operating Lease, Liability | $574,000 | $536,000 | $543,000 | $543,000 |
| Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization | $38,000 | $25,000 | $28,000 | $28,000 |
| Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization | $24,000 | $18,000 | $22,000 | $22,000 |
| Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization | $14,000 | $7,000 | $6,000 | $6,000 |
| Finance Lease, Liability, Current | $5,000 | $4,000 | $4,000 | $4,000 |
| Finance Lease, Liability, Noncurrent | $9,000 | $5,000 | $4,000 | $4,000 |
| Finance Lease, Liability | $14,000 | $9,000 | $8,000 | $8,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $2,966,000 | $1,810,000 | $181,000 | $233,000 |
| Depreciation | $679,000 | $753,000 | $783,000 | $675,000 |
| Amortization of Intangible Assets | $233,000 | $211,000 | $208,000 | $208,000 |
| Amortization of Debt Issuance Costs | $9,000 | $12,000 | $9,000 | $8,000 |
| Restructuring Costs | $83,000 | $-45,000 | $-10,000 | $-26,000 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-2,000 | $-40,000 | $35,000 | $-2,000 |
| Deferred Income Tax Expense (Benefit) | $-2,164,000 | $-34,000 | $394,000 | $56,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $85,000 | $-66,000 | $280,000 | $-684,000 |
| Pension and Other Postretirement Benefits Cost (Reversal of Cost) | $44,000 | $44,000 | $44,000 | $31,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $1,640,000 | $1,574,000 | $1,854,000 | $3,930,000 |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | $-304,000 | $-130,000 | $-58,000 | $-63,000 |
| Gain (Loss) on Extinguishment of Debt | $-1,000 | $-15,000 | $-2,000 | $40,000 |
| Gain (Loss) on Disposition of Other Assets | $-2,000 | $-6,000 | $2,000 | $-3,000 |
| Goodwill, Impairment Loss | $0 | $0 | $648,000 | $648,000 |
| Share-based Payment Arrangement, Noncash Expense | $115,000 | $120,000 | $139,000 | $118,000 |
| Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee | — | $605,000 | $46,000 | $3,000 |
| Payments to Acquire Productive Assets | $906,000 | $830,000 | $656,000 | $588,000 |
| Proceeds from Sale of Property, Plant, and Equipment | $4,000 | $6,000 | $16,000 | $16,000 |
| Proceeds from Sale of Other Productive Assets | — | — | $4,000 | $4,000 |
| Proceeds from Divestiture of Businesses, Net of Cash Divested | $-17,000 | $0 | $0 | $-4,000 |
| Payments to Acquire Businesses, Net of Cash Acquired | $83,000 | $0 | $0 | $0 |
| ProceedsFromSaleOfEquitySecuritiesFvNi | $0 | $0 | $12,000 | $11,000 |
| Payments to Acquire Interest in Joint Venture | $6,000 | $121,000 | $42,000 | $0 |
| Proceeds from Sale of Equity Method Investments | — | $448,000 | $164,000 | $0 |
| Payments to Acquire Short-term Investments | — | $748,000 | $0 | $0 |
| Proceeds from Sale, Maturity and Collection of Short-term Investments | — | $740,000 | $0 | $0 |
| Payments for (Proceeds from) Derivative Instrument, Investing Activities | $-6,000 | $2,000 | $-4,000 | $4,000 |
| Net Cash Provided by (Used in) Investing Activities | $-1,002,000 | $-507,000 | $-498,000 | $-698,000 |
| Proceeds from (Repayments of) Other Debt | $-23,000 | $454,000 | $-462,000 | $-9,000 |
| Proceeds from (Repayments of) Other Long-term Debt | — | $598,000 | $0 | $736,000 |
| Repayments of Other Long-term Debt | $309,000 | $350,000 | $250,000 | $0 |
| Repayments of Unsecured Debt | $0 | $1,440,000 | $296,000 | $2,350,000 |
| Proceeds from Issuance of Unsecured Debt | $0 | $2,920,000 | $0 | $1,577,000 |
| Proceeds from Short-term Debt | — | $2,483,000 | $0 | $0 |
| Payments of Financing Costs | $0 | — | $5,000 | $0 |
| Repayments of Short-term Debt | — | $2,500,000 | $0 | $0 |
| Payment for Contingent Consideration Liability, Financing Activities | $10,000 | $0 | $0 | $0 |
| Payments of Ordinary Dividends, Noncontrolling Interest | $2,000 | $0 | $6,000 | $10,000 |
| Payments for Repurchase of Common Stock | $398,000 | $4,104,000 | $397,000 | $719,000 |
| Payments of Ordinary Dividends, Preferred Stock and Preference Stock | $32,000 | $0 | $0 | $0 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $33,000 | $23,000 | $26,000 | $39,000 |
| Net Cash Provided by (Used in) Financing Activities | $-807,000 | $-1,965,000 | $-1,442,000 | $-1,335,000 |
| Capital Expenditures Incurred but Not yet Paid | $293,000 | $222,000 | $256,000 | $223,000 |
| Increase (Decrease) in Accounts Receivable | $112,000 | $-285,000 | $216,000 | $74,000 |
| Increase (Decrease) in Inventories | $20,000 | $-45,000 | $241,000 | $316,000 |
| Increase (Decrease) in Other Current Assets | $187,000 | $15,000 | $122,000 | $214,000 |
| Increase (Decrease) in Accounts Payable | $4,000 | $-210,000 | $251,000 | $153,000 |
| Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | $0 | $60,000 | $125,000 | $7,000 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $28,000 | $104,000 | $-10,000 | $5,000 |
| Payment for Pension and Other Postretirement Benefits | $33,000 | $32,000 | $30,000 | $28,000 |
| Net Cash Provided by (Used in) Operating Activities | $1,896,000 | $2,446,000 | $2,185,000 | $1,351,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,640,000 | $1,574,000 | — | $1,574,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations | $0 | $0 | — | $0 |